Prenetics Global (NASDAQ:PRE) Posts Earnings Results

Prenetics Global (NASDAQ:PRE) posted its earnings results on Tuesday. The company reported ($0.52) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.84) by $0.32, FiscalAI reports. The firm had revenue of $46.49 million for the quarter, compared to the consensus estimate of $49.85 million. Prenetics Global had a negative net margin of 62.45% and a negative return on equity of 20.33%.

Prenetics Global Stock Down 1.9%

NASDAQ PRE opened at $19.37 on Tuesday. The company has a fifty day moving average of $19.17 and a two-hundred day moving average of $18.90. The firm has a market capitalization of $326.77 million, a price-to-earnings ratio of -4.23 and a beta of 0.26. Prenetics Global has a 52 week low of $7.18 and a 52 week high of $23.63.

Wall Street Analysts Forecast Growth

PRE has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of Prenetics Global from a “hold” rating to a “sell” rating in a report on Saturday, July 25th. Benchmark boosted their price objective on Prenetics Global from $30.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, July 15th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Prenetics Global in a research report on Friday, July 17th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $34.25.

Institutional Investors Weigh In On Prenetics Global

Institutional investors have recently made changes to their positions in the company. Quadrature Capital Ltd purchased a new position in shares of Prenetics Global during the 4th quarter worth about $468,000. Millennium Management LLC bought a new position in Prenetics Global during the 4th quarter valued at about $810,000. Boothbay Fund Management LLC purchased a new stake in Prenetics Global in the 4th quarter worth about $241,000. Jump Financial LLC purchased a new stake in Prenetics Global in the 4th quarter worth about $268,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in Prenetics Global in the fourth quarter worth about $307,000. Institutional investors own 25.01% of the company’s stock.

Prenetics Global Company Profile

Prenetics Global (NASDAQ: PRE) is a molecular diagnostics and genetic testing company that delivers a broad range of laboratory and at-home testing solutions. The company’s core offerings include next-generation sequencing (NGS) panels for hereditary health risks, pharmacogenomic reports to guide medication choices, and comprehensive consumer DNA testing services. In addition to genetic insights, Prenetics provides infectious disease diagnostics—most notably real-time PCR testing for pathogens such as SARS-CoV-2—through an integrated platform that combines sample collection, laboratory processing and digital reporting.

Serving both business-to-consumer and business-to-business markets, Prenetics operates a network of laboratories and service centers across Asia Pacific, Europe, the Middle East and North America.